Given their overexpression in certain cancers, formins have the potential to serve as biomarkers for diagnosis and prognosis. For example, elevated levels of DIAPH3 have been associated with poor prognosis in breast cancer patients. Detection of specific formin expression patterns could help in identifying aggressive forms of cancer and tailoring treatment strategies accordingly.